Top

Osteoporosis International

Published in:

01-10-2009 | Original Article

BMD, clinical risk factors and their combination for hip fracture prevention

Authors: H. Johansson, J. A. Kanis, A. Oden, O. Johnell, E. McCloskey

Published in: Osteoporosis International | Issue 10/2009

Abstract

Summary

This study examined the effects of the use of clinical risk factors (CRFs) alone, BMD alone or the combination using the FRAX® tool for the detection of women at risk of hip fracture. BMD tests alone selected women at higher risk and a greater number of hip fracture cases were identified compared to the use of CRFs alone. The combined use of CRFs and BMD identified fewer women above a threshold risk than the use of BMD alone, but with a higher hip fracture risk and thus had the more favourable positive predictive value (PPV) and number needed to treat (NNT).

Introduction

Algorithms have recently become available for the calculation of hip fracture probability from CRFs with and without information on femoral neck BMD. The aim of this study was to examine the effects of the use of CRFs alone, BMD alone or their combination using the FRAX® tool for the detection of women at risk of hip fracture.

Methods

Data from 10 prospective population based cohorts, in which BMD and CRFs were documented, were used to compute the 10-year probabilities of hip fracture calibrated to the fracture and death hazards of the UK. The effects of the use of BMD tests were examined in simulations where BMD tests were used alone, CRFs alone or their combined use. The base case examined the effects in women at the age of 65 years. The principal outcome measures were the number of women identified above an intervention threshold, the number of hip fracture cases that would be identified, the positive predicted value and the NNT to prevent a hip fracture during a hypothetical treatment with an effectiveness of 35% targeted to those above the threshold fracture risk. We also examined BMD values in women selected for treatment. Sensitivity analysis examined the effect of age and limited use of BMD resources.

Results

BMD tests alone selected women at higher risk of hip fracture than the use of CRFs alone (6.1% versus 5.3%). BMD tests alone also identified a greater number of hip fracture cases (219/1,000) compared to the use of CRFs alone (140/1,000). The combined use of CRFs and BMD identified fewer women above a threshold risk than the use of BMD alone (168/1,000 versus 219/1,000, respectively), but with a higher hip fracture risk (PPV, 8.6% versus 6.1%), and consequently a lower number needed to treat (NNT) (33 versus 47). In sensitivity analyses, the PPV and NNT were always better for the combination than either BMD or CRFs alone across all ages studied (50–70 years).

Conclusions

The use of FRAX® in combination with BMD increases the performance characteristics of fracture risk assessment.

Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 312:1254–1259

Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA et al (2005) Predictive value of bone mineral density for hip and other fractures. J Bone Miner Res 20:1185–1194PubMedCrossRef

Kanis JA, Johnell O, Oden A, Jönsson B, De Laet C, Dawson A (2000) Risk of hip fracture according to World Health Organization criteria for osteopenia and osteoporosis. Bone 27:585–590PubMedCrossRef

Hui SL, Slemenda CW, Johnston CC (1988) Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 81:1804–1809PubMedCrossRef

De Laet CEDH, van Hout BA, Burger H, Hofman A, Pols HAP (1997) Bone density and risk of hip fracture in men and women: cross sectional analysis. Br Med J 315:221–225

World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. WHO, Geneva

De Laet C, Oden A, Johansson H, Johnell O, Jonsson B, Kanis JA (2005) The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int 16:313–318PubMedCrossRef

Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA et al (2001) Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 286:2815–2822PubMedCrossRef

Kanis JA, Johnell O, Oden A, Jönsson B, Dawson A, Dere W (2000) Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden. Osteoporos Int 11:120–127PubMedCrossRef

10.

Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A (2002) Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30:251–285PubMedCrossRef

11.

Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Eisman JA et al (2004) A family history of fracture and fracture risk: a meta-analysis. Bone 35:1029–1037PubMedCrossRef

12.

Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Melton LJ III et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893–899PubMedCrossRef

13.

Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382PubMedCrossRef

14.

Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA et al (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737–742PubMedCrossRef

15.

Kanis JA, Johansson H, Oden A et al (2005) A meta-analysis of milk intake and fracture risk: low utility for case finding. Osteoporos Int 16:799–804PubMedCrossRef

16.

Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA et al (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:155–162PubMedCrossRef

17.

De Laet C, Kanis JA, Oden A, Johansson H, Johnell O, Delmas P et al (2005) Body mass index as a prediction of fracture risk. A meta-analysis. Osteoporos Int 16:1330–1338PubMedCrossRef

18.

Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046PubMedCrossRef

19.

Kanis JA, Johnell O, Oden A, McCloskey E (2008) FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397PubMedCrossRef

20.

Kanis JA on behalf of the World Health Organization Scientific Group (2008) Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK, 2008

21.

Kanis JA, Johnell O (2005) Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int 16:229–238PubMedCrossRef

22.

Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D, European Foundation for Osteoporosis and Bone Disease (1997) Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 7:390–406PubMedCrossRef

23.

Royal College of Physicians (1999) Osteoporosis: clinical guidelines for prevention and treatment. The Royal College of Physicians of London

24.

Royal College of Physicians (2001) Osteoporosis: clinical guidelines for prevention and treatment. Update on pharmacological interventions and an algorithm for management. RCP, London

25.

Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA (1991) Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7:403–422PubMedCrossRef

26.

De Laet CEDH, Van Hout BA, Burger H, Hofman A, Weel AEAM, Pols HAP (1998) Hip fracture prediction in elderly men and women: validation of the Rotterdam study. J Bone Miner Res 13:1587–1593PubMedCrossRef

27.

O’Neill TW, Felsenberg D, Barlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11:1010–1017PubMedCrossRef

28.

Kreiger N, Tenenhouse A, Joseph L et al (1999) The Canadian Multicentre Osteoporosis Study CaMos: background, rationale, methods. Can J Aging 18:376–387

29.

Melton LJ III, Crowson CS, O’Fallon WM, Wahner HW, Riggs BL (2003) Relative contributions of bone density, bone turnover and clinical risk factors to long-term fracture prediction. J Bone Miner Res 18:312–318PubMedCrossRef

30.

Melton LJ III, Atkinson EJ, O’Connor MK, O’Fallon WM, Riggs BL (1998) Bone density and fracture risk in men. J Bone Miner Res 13:1915–1923PubMedCrossRef

31.

McCloskey EV, Beneton M, Charlesworth D, Kayan K, deTakats D, Dey A et al (2007) Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res 22:135–141PubMedCrossRef

32.

Jones G, Nguyen TV, Sambrook PN, Kelly PJ, Gilbert C, Eisman JA (1994) Symptomatic fracture incidence in elderly men and women. The Dubbo Osteoporosis Epidemiology Study DOES. Osteoporos Int 4:277–282PubMedCrossRef

33.

Svanborg A (1977) 70 year old people in Gothenburg. A population study in an industrialised Swedish city. II. Journal presentation of social and medical conditions. Acta Med Scand 611(suppl):5

34.

Johansson C, Black D, Johnell O, Oden A, Mellstrom D (1998) Bone mineral density is a predictor of survival. Calcif Tissue Int 63:190–196PubMedCrossRef

35.

Fujiwara S, Kasagi F, Yamada M, Kodama K (1997) Risk factors for hip fracture in Japanese cohort. J Bone Miner Res 12:998–1004PubMedCrossRef

36.

Fujiwara S, Fumiyoshi K, Masunari W, Narito K, Suzuki G, Fukunagi M (2003) Fracture prediction from bone mineral density in Japanese men and women. J Bone Miner Res 18:1547–1553PubMedCrossRef

37.

Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Oglesby A (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–1244PubMedCrossRef

38.

National Osteoporosis Foundation (NOF) (2003) Physician’s Guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC (http://www.nof.org/physguide/Physicians_Guide.pdf)

39.

Kanis JA, Borgstrom F, Zethraeus N, Johnell O, Oden A, Jonsson B (2005) Intervention thresholds for osteoporosis in the UK. Bone 36:22–32PubMedCrossRef

40.

Johansson H, Oden A, Johnell O, Jonsson B, De Laet C, Oglesby A et al (2004) Optimisation of BMD measurements to identify high risk groups for treatment—a test analysis. J Bone Miner Res 19:906–913PubMedCrossRef

41.

Borgstrom F, Johnell O, Kanis JA, Jonsson B, Renhberg C (2006) At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis. Osteoporos Int 17:1459–1471PubMedCrossRef

42.

Deeks JJ, Altman DG (2004) Diagnostic tests 4: likelihood ratios. Br Med J 329:168–169CrossRef

43.

Brown J, Josse RG, The Scientific Advisory Council of the Osteoporosis Society of Canada (2002) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Canad Med Assoc J 167(suppl 10):S1–S34

44.

Community European (1998) Report on osteoporosis in the European Community. EC, Strasbourg

45.

Kanis JA, Burlet N, Cooper C, On behalf of the European Society for Clinical, Economic Aspects of Osteoporosis, Osteoarthritis (ESCEO) et al (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399–428PubMedCrossRef

46.

Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929–1936PubMedCrossRef

47.

De Laet C, Oden A, Johnell O, Jonsson B, Kanis JA (2005) The impact of the use of multiple risk factors on case finding strategies: a mathematical framework. Osteoporos Int 16:313–318PubMedCrossRef

48.

McCloskey E, Johansson H, Oden A, Jalava T, Kanis J (2008) Efficacy of clodronate on fracture risk in women selected by 10-year fracture probability. J Bone Miner Res 22(1):S17

49.

Kanis JA, Johansson H, Oden A, McCloskey EV (2008) Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®. Bone, in press

50.

Kanis JA, Oden A, Johnell O, Jonsson B, De Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417–427PubMedCrossRef

Title: BMD, clinical risk factors and their combination for hip fracture prevention
Authors: H. Johansson
J. A. Kanis
A. Oden
O. Johnell
E. McCloskey
Publication date: 01-10-2009
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 10/2009
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-009-0845-x

At a glance: The STEP trials

Springer Medicine

BMD, clinical risk factors and their combination for hip fracture prevention

Abstract

Summary

Introduction

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 10/2009

Combining bone resorption markers and heel quantitative ultrasound to discriminate between fracture cases and controls

Prediction of hip and other osteoporotic fractures from hip geometry in a large clinical cohort

Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans

Bone micro-architecture and determinants of strength in the radius and tibia: age-related changes in a population-based study of normal adults measured with high-resolution pQCT

Comparative gastrointestinal safety of weekly oral bisphosphonates

Use of anti-depressants and the risk of fracture of the hip or femur